Skip Navigation



International Immunology Advance Access published online on May 9, 2008
International Immunology, doi:10.1093/intimm/dxn044
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/7/861    most recent
dxn044v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bonelli, M.
Right arrow Articles by Scheinecker, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonelli, M.
Right arrow Articles by Scheinecker, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Japanese Society for Immunology. 2008. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)

Michael Bonelli, Anastasia Savitskaya, Karolina von Dalwigk, Carl Walter Steiner, Daniel Aletaha, Josef S. Smolen and Clemens Scheinecker

Division of Rheumatology, Internal Medicine III, General Hospital of Vienna, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Wien, Austria

Correspondence to: Correspondence to: C. Scheinecker; E-mail: clemens.scheinecker{at}meduniwien.ac.at

The objective of the study was that the regulatory T cells (Treg) that specialize in the suppression of immune responses might be critically involved in the pathogenesis of autoimmune disease. As for systemic lupus erythematosus (SLE), however, published data concerning Treg phenotype and function are partly conflicting. We therefore performed quantitative and qualitative analyses of naturally occurring CD4+CD25+ Treg from SLE patients as compared with healthy controls (HC) in order to further elucidate the role of Treg in this systemic autoimmune disease. The phenotype of peripheral blood CD4+CD25+ Treg was determined by flow cytometry (FACS) in SLE patients and HC. Treg were isolated from SLE patients and HC and their functional capacity was analyzed in suppression assays. Phenotypic and functional data were correlated with clinical data. Decreased proportions of CD4+ Treg with high-level expression of CD25 (CD4+CD25hi) were observed in active and inactive SLE patients (0.96 ± 0.08 and 1.17 ± 0.08%, respectively) as compared with HC (2 ± 0.1%). In contrast to HC, Treg from SLE patients displayed an activated phenotype as determined by the expression of CD69, CD71 and HLA-DR. The suppressive capacity of isolated Treg from SLE patients, however, was significantly reduced as compared with HC. Proportions of CD4+CD25hi T cells and the suppressive capacity of Treg were inversely correlated with the clinical disease activity in SLE patients. Our data describe quantitative and qualitative defects of Treg in SLE patients. These deficiencies might contribute to the breakdown of self-tolerance and the development of the autoimmune response in SLE patients.

Keywords: regulatory T cells, SLE, systemic lupus erythematosus

Transmitting editor: A. Falus

Received 25 December 2007, accepted 8 April 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.